Petra Nitschke, Biopharma Insights Contributor, Business Development CEVEC Pharmaceuticals GmbH

CEVEC Pharmaceuticals GmbH

Petra Nitschke is your initial point of contact for CEVEC. Before joining the company in 2019 she held various positions in Business Development, Marketing and Finance, both, in large multinational corporations, including Novartis, as well as in a Bio-Engineering startup.


ELEVECTA® - The Next Level in Gene Therapy AAV Production

Introduction of ELEVECTA®, CEVEC’s fully scalable and stable production platform for AAV gene therapy viral vector manufacturing.